March 2, 2005 — The U.S. Food and Drug Administration (FDA) approved in December 2004 revisions to safety labeling to advise healthcare professionals of the following changes: use of hydroxyzine ...
WASHINGTON (Reuters Health) - A new warning has been added to the label of the cancer drug Novaldex (tamoxifen citrate), noting that the drug has been linked to a certain type of uterine cancer, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results